![Jean Jacques Mention](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Jean Jacques Mention is currently the Chief Business Officer at OSE Immunotherapeutics SA. Prior to this, he held positions as Director of Business Development at Axenis SAS and Head of Business Development at genOway SA.
Postes actifs de Jean Jacques Mention
| Sociétés | Poste | Début |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Corporate Officer/Principal | - |
Anciens postes connus de Jean Jacques Mention
| Sociétés | Poste | Fin |
|---|---|---|
| GENOWAY | Corporate Officer/Principal | - |
Axenis SAS
 Axenis SAS BiotechnologyHealth Technology Develops gene technology and products | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
genOway SA
 genOway SA BiotechnologyHealth Technology Develops gene technology | Health Technology |
OSE Immunotherapeutics SA
 OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
Axenis SAS
Axenis SAS BiotechnologyHealth Technology Develops gene technology and products | Health Technology |
Choisissez Zonebourse 
